AAV-mediated CBLN1 replacement rescues hereditary ataxia caused by biallelic CBLN1 variants.
These findings establish CBLN1 deficiency as a cause of hereditary ataxia and identify extracellular CBLN1 replacement as a therapeutic strategy for a reversible cerebellar synaptopathy.